GRIDAI TECHNOLOGIES CORP
GRDXNASDAQ๐ #4359 by market capUS Equity
$3.23โผ $0.11 (โ3.15%)
Market closed ยท at closeTrack GRDX
Get earnings, price moves & breaking news on Telegram
24hโผ 3.1%
7dโผ 17.3%
14dโผ 33.8%
30dโผ 42.2%
ytdโผ 28.1%
1yโฒ 19.6%
๐ฆMarket Cap
$22M
Small Cap
๐Revenue Growth (YoY)
โ
๐Gross Margin
โ
๐ตFCF Margin
โ
โ๏ธP/S Ratio
โ
Otter Score
โ
Insufficient data
Trading Snapshot
- Day Range
- $3.15 โ $3.52
- 52-Week Range
- $1.87 โ $6.93
- Volume (shares)
- 5,270
- Avg Volume (shares)
- โ
- Shares Outstanding
- 6.8M
- Next Earnings
- โ
Fundamentals Snapshot
- Annual Revenue
- $36,251
- Last Q Revenue
- $85,876
- P/E Ratio
- โ
- P/S Ratio
- โ
- EPS (TTM)
- $-5.31
- Dividend Yield
- โ
GRIDAI TECHNOLOGIES CORP
GRDXFinancial Trends
Financial history unavailable.
About GRIDAI TECHNOLOGIES CORP
GridAI Technologies Corp. functions as a clinical-stage biopharmaceutical enterprise primarily dedicated to developing precise, locally-acting treatments for various digestive system ailments. Its core activity involves researching and advancing therapeutic solutions specifically designed for patients with gastrointestinal diseases. The company's pipeline features several key drug candidates, including Latiglutenase, Capeserod, Adrulipase, and Niclosamide. GridAI Technologies was established on January 30, 2014, and maintains its principal offices in Boca Raton, Florida.
๐ฆฆ
Otter Score Breakdown
How it's scoredFive components, each rated 1โ5โ and equally weighted (20%), averaged to a 0โ100 score:๐ Quality โ gross margin๐ Growth โ revenue YoYโ๏ธ Valuation โ P/S ratioโก Momentum โ 30-day price change๐ง Dilution โ 1-yr share issuance (buybacks score higher)Insufficient data for all five components.
Overall Score
Insufficient data
โ/100
Analyst data unavailable.
Latest News & Updates
News unavailable.